These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
62 related articles for article (PubMed ID: 1578846)
1. [The use of thyrotropin-releasing hormone in clinical practice as a lymphatic stimulator in the treatment of acute pancreatitis]. Shimanko II; Limarev VM; Ashmarin IP; Lelekova TV; Sanzhieva LTs Khirurgiia (Mosk); 1992 Jan; (1):64-6. PubMed ID: 1578846 [TBL] [Abstract][Full Text] [Related]
2. Thyrotropin-releasing hormone in acute pancreatitis. A preliminary report. Kiviniemi H; Laitinen S; Ståhlberg M; Larmi M; Kairaluoma M Acta Chir Scand; 1986 Jan; 152():43-7. PubMed ID: 2420106 [TBL] [Abstract][Full Text] [Related]
3. Protective effect of central thyrotropin-releasing hormone analog on cerulein-induced acute pancreatitis in rats. Yoneda M; Goto M; Nakamura K; Shimada T; Hiraishi H; Terano A; Haneda M Regul Pept; 2005 Feb; 125(1-3):119-24. PubMed ID: 15582722 [TBL] [Abstract][Full Text] [Related]
4. Ghrelin attenuates the development of acute pancreatitis in rat. Dembinski A; Warzecha Z; Ceranowicz P; Tomaszewska R; Stachura J; Konturek SJ; Konturek PC J Physiol Pharmacol; 2003 Dec; 54(4):561-73. PubMed ID: 14726611 [TBL] [Abstract][Full Text] [Related]
5. [Thyroliberin: new physiological effects and prospects of clinical use]. Ashmarin IP; Gurskaia IE; Guseva AA; Lelekova TV; Sanzhieva LCh; Chepurnov SA; Chepurnova NE; Shimanko II; Limarev VM; Gavriushov VV Vestn Ross Akad Med Nauk; 1992; (6):40-4. PubMed ID: 1384890 [TBL] [Abstract][Full Text] [Related]
6. [Effects of femto- and picomolar concentrations of thyroliberin and tuftsin on the contractile activity of lymphatic vessels of the rat mesentery]. Lelekova TV; Romanovskiĭ PIa; Aleksandrov PN; Ashmarin IP Biull Eksp Biol Med; 1989 Jul; 108(7):8-10. PubMed ID: 2508788 [TBL] [Abstract][Full Text] [Related]
7. Thyrotrophin-releasing hormone--a powerful stimulator of lymphatic vessel contraction in rat mesentery. Lelekova TV; Sanzhieva LTs; Ashmarin IP Biomed Sci; 1990 Jan; 1(1):99. PubMed ID: 2130923 [No Abstract] [Full Text] [Related]
15. [Direct and prolonged effect of thyroliberin in ultra small doses on contractility of the white rat mesentery lymphatic vessels]. Sanzhieva LTs; Lelekova TV; Ashmarin IP Radiats Biol Radioecol; 2003; 43(3):334-6. PubMed ID: 12881991 [TBL] [Abstract][Full Text] [Related]
16. Suppression of the thyrotropin response to thyrotropin-releasing hormone and its association with severity of critical illness. Sumita S; Ujike Y; Namiki A; Watanabe H; Kawamata M; Watanabe A; Satoh O Crit Care Med; 1994 Oct; 22(10):1603-9. PubMed ID: 7924372 [TBL] [Abstract][Full Text] [Related]
17. ECT and TRH: cholinergic involvement in a cognitive deficit state. Khan A; Mirolo MH; Lai H; Claypoole K; Bierut L; Malik R; Bhang J Psychopharmacol Bull; 1993; 29(3):345-52. PubMed ID: 8121962 [TBL] [Abstract][Full Text] [Related]
19. [Possibilities in the use of thyrotropin-releasing hormone (TRH)]. Retiene K; Schulz F; Müller A Med Klin; 1973 Sep; 68(36):1146-50. PubMed ID: 4199832 [No Abstract] [Full Text] [Related]
20. Effects of thyrotropin-releasing hormone on acute experimental traumatic head injury in cats. Wang GL; Zhu C Chin Med J (Engl); 1991 Nov; 104(11):939-44. PubMed ID: 1800036 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]